You are here

  • Home
  • Archive
  • Volume 69, Issue 6
  • Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF

Clinical and epidemiological research
Extended report
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

Authors

  1. Correspondence to Professor Deborah Symmons, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK; deborah.symmons{at}manchester.ac.uk
View Full Text

Citation

Dixon WG, Hyrich KL, Watson KD on behalf of the British Society for Rheumatology Biologics Register, et al
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
Annals of the Rheumatic Diseases 2010;69:1086-1091.

Publication history

  • Accepted December 3, 2009
  • First published May 5, 2010.
Online issue publication 
May 24, 2010

Article Versions

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl